ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1324

Similar Negative Effects of Fatigue on Physical Activity in Persons with Rheumatoid Arthritis and Healthy Controls: A Patient-Control Study

Maartje Cox1, Kyra Theunissen2, Kenneth Meijer2, Annick Timmermans3, Sofia Ramiro4, Annelies Boonen5 and Guy Plasqui2, 1Australian National Phenome Centre - Murdoch University, Booragoon, Western Australia, Australia, 2Maastricht University, Maastricht, Netherlands, 3Universiteit Hasselt, Hasselt, 4Leiden University Medical Center, Bunde, Netherlands, 5Maastricht University Medical Centre+ & Maastricht University, Maastricht, Limburg, Netherlands

Meeting: ACR Convergence 2025

Keywords: Fatigue, physical activity, physical therapy, quality of life, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1306–1346) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: People with rheumatoid arthritis (pwRA) are prone to fall short of the World Health Organization’s physical activity (PA) recommendations due to perceived fatigue and pain. Given the high prevalence of fatigue and its impact on health-related quality of life and social participation, this study investigated objectively measured PA patterns and the association between PA and self-reported fatigue in pwRA compared to healthy controls (HC).

Methods: In this observational cross-sectional study, pwRA (DAS28 > 2.6) and HC wore a tri-axial accelerometer (ActiGraph wGT3X-BT, ActiGraph LLC) on one ankle for ≥4 days. Accelerometer-based outcomes included vector magnitude counts/min (square root of summed sagittal, frontal, and vertical axes’ counts/min squared – primary outcome), step count, and time spent in moderate-to-vigorous intensity PA. Data were separated by day and time (weekday/weekend; daytime/evening) to investigate PA patterns. Fatigue severity was assessed using the Fatigue Severity Scale (FSS, 0–7). Associations between fatigue, RA status, and PA were examined using multilevel generalized estimating equations models (patient and day-timing as levels). Interactions between RA and fatigue were tested. Manual forward selection identified multivariable associations adjusted for confounders.

Results: Participants included 23 pwRA (20 females, age 52 (SD 13), FSS 4.7 (1.4)) and 18 HC (14 females, age 52 (11), FSS 2.1 (1.0)). Vector magnitude counts/min were lower in pwRA than HC at any time, with non-significant differences on weekday daytime (1534.3 (691.3) in pwRA vs 1802.6 (610.6) in HC), and larger differences on weekday evenings (880.7 (491.4) vs 1457.3 (572.7)) (Figure 1). Step count was also lower in pwRA (587 (226) vs 724 (224) steps/h), as was time spent in moderate-to-vigorous PA (1.6 (1.4) vs 2.7 (1.5) min/h). No interaction was found between fatigue and RA, indicating that fatigue affected PA similarly in both groups. Likewise, no interaction between group and day-timing was observed, suggesting comparable daily PA patterns in pwRA and HC. RA was significantly and negatively associated with vector magnitude counts/min after adjusting for confounders (β = -330.63; 95% CI = -650.45 to -10.81; Table 1). In the multivariable model, lower vector magnitude counts/min was seen in pwRA, persons with higher fatigue severity (β = -43.89; 95% CI = -135.26 to 47.48), and in persons with higher BMI (β = -27.18; 95% CI = -50.73 to -3.62). BMI, RA presence, and fatigue were similarly negatively associated with step count and time spent in moderate-to-vigorous PA.

Conclusion: pwRA performed less objectively measured PA than HC. Fatigue was inversely associated with PA, with no differential impact between groups. Future research should examine the role of transient vs persistent fatigue, employability, inflammation, and medication use in PA participation. This may identify which patients are most at risk of falling short of PA guidelines and help design effective interventions.

Supporting image 1Figure 1: Vector Magnitude counts per minute (mean counts/min per hour) measured in rheumatoid arthritis patients (RA) and healthy controls (HC) overall (A), on weekdays as compared to the weekend (B), during the day and during the evening (C), and separated by day as well as timing of the day (D). ns p > .05, * p < .05, ** p < .01, *** p < .001, **** p < .0001

Supporting image 2


Disclosures: M. Cox: None; K. Theunissen: None; K. Meijer: None; A. Timmermans: None; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, 5, Galapagos/Alfasigma, 2, 5, Janssen, 2, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5; A. Boonen: AbbVie/Abbott, 5, Alfasigma, 2, Celgene, 5, Eli Lilly, 2, Novartis, 2, Sandoz, 2, UCB, 2; G. Plasqui: None.

To cite this abstract in AMA style:

Cox M, Theunissen K, Meijer K, Timmermans A, Ramiro S, Boonen A, Plasqui G. Similar Negative Effects of Fatigue on Physical Activity in Persons with Rheumatoid Arthritis and Healthy Controls: A Patient-Control Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/similar-negative-effects-of-fatigue-on-physical-activity-in-persons-with-rheumatoid-arthritis-and-healthy-controls-a-patient-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/similar-negative-effects-of-fatigue-on-physical-activity-in-persons-with-rheumatoid-arthritis-and-healthy-controls-a-patient-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology